Infant mandatory vaccinations: Confirmation of a positive impact.


Journal

Medecine et maladies infectieuses
ISSN: 1769-6690
Titre abrégé: Med Mal Infect
Pays: France
ID NLM: 0311416

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 21 11 2019
revised: 27 11 2019
accepted: 29 11 2019
pubmed: 18 12 2019
medline: 8 1 2021
entrez: 18 12 2019
Statut: ppublish

Résumé

Infant vaccines protecting against 11 diseases have changed from recommended to mandatory status in France for all children born from first of January 2018. Through Vaccinoscopie survey, we measured for the second consecutive year the impact of this new policy on vaccine coverage rates (VCRs) and mothers' perception regarding vaccination. Web-based survey on a representative sample of 1500 mothers of 0 to 17-month-old infants. Non-optimal VCRs continued to increase in 2019 versus 2017 (according to age, +7 to 8 points VCR for Hepatitis B and +36 to 68 points for Meningococcus C). After a progressive decrease between 2012 and 2017, the rate of favorable mothers' opinion towards vaccination continued to progress in 2018 and 2019. These results confirmed the positive impact of this new law on infant VCRs and mothers' favorable opinion regarding vaccination.

Identifiants

pubmed: 31843343
pii: S0399-077X(19)31075-3
doi: 10.1016/j.medmal.2019.11.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

74-77

Informations de copyright

Copyright © 2019 GlaxoSmithKline Biologicals SA. Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

R Cohen (R)

Unité court séjour petits nourrissons, CHI de Créteil, 40, avenue de Verdun, 94010 Créteil cedex, France.

A Martinot (A)

EA 2694 - Santé publique: épidémiologie et qualité des soins, University Lille, CHU de Lille, 59000 Lille, France.

J Gaudelus (J)

Service de pédiatrie, hôpital Jean-Verdier, 93140 Bondy, France; Université Paris-XIII, 93017 Bobigny, France.

D Subtil (D)

Service de gynéco-obstétrique, CHU de Lille, Lille, France.

J-P Stahl (JP)

Service de maladies infectieuses et tropicales, université-1 de Grenoble, CHU, BP 217, 38043 Grenoble, France.

P Pujol (P)

GSK France, 23, rue François-Jacob, 92500 Rueil-Malmaison, France. Electronic address: patricia.p.pujol@gsk.com.

V Picquet (V)

GSK France, 23, rue François-Jacob, 92500 Rueil-Malmaison, France.

H Lepetit (H)

IDM - Families, 10, boulevard des Frères Voisin, 92130 Issy-les-Moulineaux, France.

L Longfier (L)

IDM - Families, 10, boulevard des Frères Voisin, 92130 Issy-les-Moulineaux, France.

B Leboucher (B)

Unité de réanimation et médecine néonatales, pôle Femme-Mère-Enfant, CHU d'Angers, 4, rue Larrey, 49933 Angers cedex 9, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH